Ignite Creation Date:
2025-12-24 @ 5:24 PM
Ignite Modification Date:
2026-02-20 @ 4:44 PM
Study NCT ID:
NCT01849250
Status:
COMPLETED
Last Update Posted:
2021-12-28
First Post:
2013-05-06
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of Docosahexaenoic Acid (DHA) in Triple Negative Breast Cancer Survivors
Sponsor:
National Cancer Institute (NCI)
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Benign Breast Neoplasm | View |
| None | Ductal Breast Carcinoma In Situ | View |
| None | Invasive Breast Carcinoma | View |
| None | Lobular Breast Carcinoma In Situ | View |
| None | Paget Disease of the Breast | View |
| None | Stage IA Breast Cancer | View |
| None | Stage IB Breast Cancer | View |
| None | Stage IIA Breast Cancer | View |
| None | Stage IIB Breast Cancer | View |
| None | Stage IIIA Breast Cancer | View |
| None | Stage IIIB Breast Cancer | View |
| None | Stage IIIC Breast Cancer | View |
Keywords: